GlassScriptPhysician profile
Katlyn Duffy
NPI 1053040311
$828.30
in general payments reported to CMS, 2019-2025
15 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.02 · 2023: $257 · 2024: $295 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $148.01 | 2023-2025 | |
| Novo Nordisk INC | $133.14 | 2023-2025 | Wegovy |
| Glaxosmithkline, LLC. | $95.39 | 2022-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Dexcom, INC. | $82.57 | 2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $78.57 | 2024 | |
| Exact Sciences Corporation | $70.58 | 2023-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $48.39 | 2024 | Korlym |
| Astrazeneca Pharmaceuticals LP | $33.95 | 2023-2025 | Airsupra, Breztri |
| Merck Sharp & Dohme LLC | $29.50 | 2022-2023 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Abbott Laboratories | $21.63 | 2024 | Freestyle Libre 3 |
| Seqirus USA INC | $19.21 | 2024 | Flucelvax, Fluad |
| Inspire Medical Systems, INC. | $18.53 | 2025 | Inspire |
| Pfizer INC. | $17.26 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.66 | 2022 | |
| Hologic Sales and Service, LLC | $14.91 | 2023 | Aptima, Third Wave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katlyn Duffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.